EAM
CTIC

Eagle Asset Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Eagle Asset Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-433,263
Closed -$7.84M – 697
2015
Q1 		$7.84M Sell
433,263
-838,042
-66% -$18.9M 0.04% 366
2014
Q4 		$30M Buy
1,271,305
+485,954
+62% +$11.2M 0.17% 179
2014
Q3 		$19M Buy
785,351
+86,785
+12% +$2.26M 0.11% 212
2014
Q2 		$19.6M Buy
698,566
+26,718
+4% +$803K 0.11% 226
2014
Q1 		$22.8M Buy
+671,848
New +$23M 0.13% 229

Other funds holding CTIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

Eagle Asset Management's CTIC Position: Q2 2015 in Review

Eagle Asset Management sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2015, closing a stake of 433,263 shares — an estimated $7.84M sold.

Eagle Asset Management first reported a position in CTIC in Q1 2014 and held it in 5 quarters. The position peaked at $30M in Q4 2014. 95 funds tracked by Wall St. Rank hold CTIC as of Q2 2015.

  • Eagle Asset Management reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2015 after selling out during the quarter.
  • Eagle Asset Management sold 433,263 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2015, an estimated $7.84M.
  • Eagle Asset Management first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2014 and held it in 5 quarters.
  • Eagle Asset Management's CTI BioPharma Corp. (DE) Common Stock position peaked at $30M in Q4 2014.
  • 95 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2015.

Based on Eagle Asset Management's 13F filing for Q2 2015, filed 15 Jul 2015.